AbbVie
ABBV
ABBV
1,995 hedge funds and large institutions have $99.1B invested in AbbVie in 2018 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 820 increasing their positions, 831 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
7% less funds holding in top 10
Funds holding in top 10: 137 → 128 (-9)
7% less capital invested
Capital invested by funds: $106B → $99.1B (-$7.4B)
26% less call options, than puts
Call options by funds: $984M | Put options by funds: $1.33B
Holders
1,995
Holding in Top 10
128
Calls
$984M
Puts
$1.33B
Top Buyers
| 1 | +$368M | |
| 2 | +$182M | |
| 3 | +$131M | |
| 4 |
AT
AMF Tjänstepension
Stockholm,
Sweden
|
+$119M |
| 5 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$117M |
Top Sellers
| 1 | -$1.1B | |
| 2 | -$583M | |
| 3 | -$375M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$373M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$353M |